We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
-7.61%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$107M
AUM Growth
-$54.2M
(-34%)
Cap. Flow
-$24M
Cap. Flow
% of AUM
-22.49%
Top 10 Holdings %
Top 10 Hldgs %
54.93%
Holding
347
New
45
Increased
19
Reduced
60
Closed
132
Avg Time Held Equity + Options
4.4
quarters
Top 10 Avg Time Held Equity + Options
2.2
quarters
Top 20 Avg Time Held Equity + Options
2.4
quarters
Avg Time Held Equity only
4.6
quarters
Top 10 Avg Time Held Equity only
3.6
quarters
Top 20 Avg Time Held Equity only
3.2
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.59M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.36M |
| 3 |
Silicon Motion
SIMO
|
+$870K |
| 4 |
Amazon
AMZN
|
+$758K |
| 5 |
LNKD
LinkedIn Corporation
LNKD
|
+$596K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
bluebird bio
BLUE
|
+$1.75M |
| 2 |
CSOD
Cornerstone OnDemand, Inc.
CSOD
|
+$957K |
| 3 |
Capri Holdings
CPRI
|
+$842K |
| 4 |
Sage Therapeutics
SAGE
|
+$803K |
| 5 |
CY
Cypress Semiconductor
CY
|
+$764K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 45.84% |
| 2 | Miscellaneous | 25.05% |
| 3 | Healthcare | 9.93% |
| 4 | Consumer Discretionary | 6.85% |
| 5 | Technology | 4.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AIMT
76
DELISTED
Aimmune Therapeutics
AIMT
| $258K | 0.24% |
+10,200
| New | +$238K |
2015 Q3
0 quarters
|
|
|
ROIQ
77
DELISTED
ROI ACQUISITION CORP II COM STK
ROIQ
| $250K | 0.23% |
+25,000
| New | +$251K |
2015 Q3
0 quarters
|
|
78
First Northwest Bancorp
FNWB
$93.7M
| $248K | 0.23% |
20,000
| – | – |
2015 Q1
2 quarters
|
|
|
ISBC
79
DELISTED
Investors Bancorp, Inc.
ISBC
| $247K | 0.23% |
20,000
| – | – |
2014 Q2
5 quarters
|
|
80
Alnylam Pharmaceuticals
ALNY
$30.4B
| $241K | 0.23% |
3,000
-4,500
| -60% | -$500K |
2014 Q2
5 quarters
|
|
81
Investar Holding Corp
ISTR
$400M
| $232K | 0.22% |
15,000
| – | – |
2014 Q3
4 quarters
|
|
82
Tejon Ranch
TRC
$442M
| $218K | 0.2% |
10,300
| – | – |
2013 Q3
8 quarters
|
|
|
CSBK
83
DELISTED
Clifton Bancorp Inc.
CSBK
| $208K | 0.2% |
15,000
| – | – |
2014 Q2
5 quarters
|
|
84
CALL
Jefferies Financial Group
JEF
$10.4B
| $203K | 0.19% |
11,171
| – | – |
2015 Q2
1 quarter
|
|
|
ATML
85
DELISTED
ATMEL CORP
ATML
| $202K | 0.19% |
+25,000
| New | +$207K |
2015 Q3
0 quarters
|
|
86
CALL
DELISTED
Edgio, Inc. Common Stock
EGIO
| $191K | 0.18% |
+2,500
| New | +$306K |
2015 Q3
0 quarters
|
|
|
KATE
87
DELISTED
Kate Spade & Company
KATE
| $191K | 0.18% |
+10,000
| New | +$200K |
2015 Q3
0 quarters
|
|
88
Teekay Tankers
TNK
$3.76B
| $186K | 0.17% |
3,375
+875
| +35% | +$47.2K |
2014 Q1
6 quarters
|
|
89
HomeTrust Bancshares
HTB
$758M
| $186K | 0.17% |
10,000
| – | – |
2013 Q2
9 quarters
|
|
|
JCP
90
DELISTED
J.C. Penney Company, Inc.
JCP
| $186K | 0.17% |
20,000
+5,000
| +33% | +$44.3K |
2015 Q1
2 quarters
|
|
|
CVA
91
DELISTED
Covanta Holding Corporation
CVA
| $175K | 0.16% |
10,000
| – | – |
2015 Q2
1 quarter
|
|
92
NeoGenomics
NEO
$2.08B
| $172K | 0.16% |
30,000
-10,000
| -25% | -$61.9K |
2014 Q2
5 quarters
|
|
93
Halozyme
HALO
$12.6B
| $168K | 0.16% |
12,500
-22,550
| -64% | -$453K |
2013 Q2
9 quarters
|
|
|
CSLT
94
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $168K | 0.16% |
40,000
-15,000
| -27% | -$94.6K |
2014 Q1
6 quarters
|
|
95
DELISTED
Primo Water Corporation
PRMW
| $162K | 0.15% |
15,000
-5,000
| -25% | -$54.1K |
2015 Q2
1 quarter
|
|
96
Novavax
NVAX
$2.09B
| $159K | 0.15% |
1,125
+125
| +13% | +$28K |
2013 Q4
7 quarters
|
|
97
DELISTED
Cogentix Medical, Inc.
CGNT
| $153K | 0.14% |
122,176
| – | – |
2015 Q2
1 quarter
|
|
98
Casella Waste Systems
CWST
$5.42B
| $145K | 0.14% |
25,000
| – | – |
2015 Q1
2 quarters
|
|
|
ENT
99
DELISTED
Global Eagle Entertainment Inc.
ENT
| $144K | 0.14% |
500
-100
| -17% | -$30.2K |
2014 Q3
4 quarters
|
|
|
BDBD
100
DELISTED
BOULDER BRANDS INC
BDBD
| $143K | 0.13% |
17,500
-17,500
| -50% | -$140K |
2015 Q1
2 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q3 2015 Portfolio in Review
As of Q3 2015, E.E. Geduld held 347 positions worth $107M, down 34% from $161M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
E.E. Geduld withdrew a net $24M in Q3 2015, closing 132 positions and reducing 60 holdings. Its most notable exit was bluebird bio, an estimated $1.75M position sold in full.
By sector, the portfolio is most concentrated in Financials at 46% of assets, up from 33% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, E.E. Geduld opened a new position in Bristol-Myers Squibb worth $1.48M.
- E.E. Geduld's largest Q3 2015 buy was Bristol-Myers Squibb: 25,000 shares worth $1.48M.
- E.E. Geduld added most to Amazon in Q3 2015, an estimated $758K increase.
- E.E. Geduld's biggest Q3 2015 reduction was Ariad Pharmaceuticals Inc, cutting an estimated $578K.
- E.E. Geduld fully exited bluebird bio in Q3 2015, selling an estimated $1.75M.
- E.E. Geduld's ten largest holdings make up 55% of its $107M portfolio in Q3 2015.
- E.E. Geduld opened 45 new positions and closed 132 in Q3 2015.
- E.E. Geduld's portfolio value fell 34% quarter-over-quarter to $107M.
Based on E.E. Geduld's 13F filing for Q3 2015, filed 6 Nov 2015.